Phosphorus Regulation in Chronic Kidney Disease

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Serum phosphorus is tightly regulated by parathyroid hormone, fibroblast growth factor 23, and vitamin D.
• Normal serum phosphorus ranges from 3-4.5 mg/dL, but atypical levels (1.6-6.2 mg/dL) occur even in individuals with normal kidney function.
• Factors influencing phosphorus levels include diet, kidney function, bone health, and hormonal regulation.

Purpose of the Study:

• To explore the complex regulation of serum phosphorus.
• To highlight the association between abnormal phosphorus levels, bone disease, and cardiovascular mortality.
• To discuss challenges in managing phosphorus levels, particularly in advanced chronic kidney disease.

Main Methods:

• Review of existing literature on serum phosphorus regulation and its clinical implications.
• Analysis of cross-sectional studies examining serum phosphorus ranges.
• Discussion of current and novel therapeutic strategies for phosphate control.

Main Results:

• Serum phosphorus levels are influenced by kidney, bone, and digestive system interactions.
• Elevated phosphorus levels are associated with increased risks of bone disease and cardiovascular mortality.
• Achieving normal phosphorus levels is challenging in end-stage kidney disease, necessitating dietary restrictions, medications, and dialysis.

Conclusions:

• Maintaining normal serum phosphorus is crucial for preventing bone disease and cardiovascular complications.
• Further research into novel therapeutic targets, such as inhibiting intestinal phosphorus transport, is needed.
• Integrated management of bone health and phosphorus levels is essential for patients with chronic kidney disease.